VRTX Sets Biotech Standards, TRVI Develops Novel Opioid Formulations


Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated is a global biotech company focused on developing therapies for serious diseases, including cystic fibrosis. Its growth is driven by a strong pipeline in gene editing and pain treatment, strategic collaborations, and consistent revenue from approved therapies. Chart

Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics, Inc. is a clinical-stage biotech company developing therapies for chronic pruritus and serious neurologic conditions. Its lead candidate, nalbuphine ER, targets opioid receptors. Growth depends on clinical milestones and the potential for treating underserved patient populations. Chart


 


Follow Trade Ideas on


 
Trending Ideas

Featured Stocks On The Move

Featured Stocks On The Move